The European Society of Oncology Pharmacy (ESOP), founded in 2000 in Prague, is the largest organisation of oncology pharmacists in the world with almost 3 000 members from 46 countries.
The aim of ESOP is to support optimal treatment for cancer patients, to develop and promote clinical and oncology pharmacy practice through education and training, safe handling and administration of drugs, quality management, research and development and pharmaceutical care.
Ljubljana Declaration 2006
‘The close cooperation between oncology physicians and oncology pharmacists is vital for optimal patient care. The multi-professional approach will deliver best practice to patients within a clinical governance frame-work. Professional, close and timely collaboration will ensure economic use of resources and improve patient safety.’
The fourth edition of Quality Standards for the Oncology Pharmacy Service (QuapoS) – translated into 27 languages – presents changes with respect to the position of our service. They are used for standardisation of national principles and to speak with one voice in Europe.
Education and Certification
ECOP - European Conference of Oncology Pharmacy
The primary focus of this unique European Conference is to promote the highest standards of pharmaceutical care in the management and support of patients with tumours. The latest advances in research, patient management and practice are being showcased in keynote lectures, scientific symposia and poster sessions. In 2014 ECOP will meet again in Krakow.
ESOP Masterclass in oncology pharmacy
The ESOP Masterclass is providing continuing education in oncology for pharma¬cists, whose duties require expertise on cytotoxic drug preparation, handling and administration (including risk management) and for clinical pharmacists, so they can give patients the best possible care and support.
ESOP-ESO Advanced Masterclass in Oncology Pharmacy
The Advanced Masterclass is tailored to experienced cancer service pharmacists who would like to enhance their knowledge in specific or specialised areas. It is mainly based on clinical cases covering the majority of diseases and pharmaceutical cases which can occur in the clinical setting.
Page last modified: